Societe Generale Corporate & Investment Banking (SG CIB) has appointed Nick Gionfriddo as Head of OTC Clearing Sales, North America within its Newedge prime services business.
Gionfriddo will be based in New York and will work closely with Jamie Gavin, who was recently appointed Head of Institutional OTC Clearing Sales, UK. He will report to Adam Cohen, Global Head of Institutional Sales.
Gionfriddo joins from CME Group where he was a Senior Director on the OTC Products team, providing services across rates, credit and FX to institutional clients. He has more than 11 years of derivatives clearing experience in operations, solutions and marketing within global financial services organizations. Prior to CME, he was a member of the UBS Securities Futures and OTC Clearing Sales desk and managed the US Client Solutions team.
Cohen, says: “As the industry continues to shift and markets become more transparent, it is incumbent on service providers to enhance their OTC Clearing capabilities to remain relevant to clients’ needs. The knowledge and experience Nick brings positions our firm well to add value and offer clients a unique perspective on the issues they face and the growing choice of products and services on offer.”
